Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Healthscope Limited |
ABN 64 144 840 639 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Paula Jane Dwyer |
Date of last notice | 16 December 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Interest prior to change: 110,000 Ordinary Shares held indirectly by Happell Company Pty Ltd as trustee for the Happell Super Fund |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | As detailed above |
Date of change | 9 May 2016 |
No. of securities held prior to change | As detailed above |
Class | As detailed above |
Number acquired | 50,000 Ordinary Shares |
Number disposed | Not applicable |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | $138,500 total trade value in respect of the purchase of Ordinary Shares |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director's Interest NoticeNo. of securities held after change | 110,000 Ordinary Shares held indirectly by Happell Company Pty Ltd as trustee for the Happell Super Fund 50,000 Ordinary Shares held indirectly by Roble Pty Limited as trustee for the Happell Family Trust |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | On-market purchase of 50,000 fully paid ordinary shares |
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | Not applicable |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
Interest after change |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No trading occurred during a closed period |
If so, was prior written clearance provided to allow the trade to proceed during this period? | |
If prior written clearance was provided, on what date was this provided? |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Healthscope Limited published this content on 13 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 May 2016 23:48:05 UTC.
Original documenthttp://www.healthscope.com.au/download_file/view_inline/562
Public permalinkhttp://www.publicnow.com/view/76385BAB8A5ECF87ABD3CB4DBF526B7E3D79B5CF